USNA USANA Health Sciences, Inc. Common Stock

NYSE · Consumer products · Ver em SEC EDGAR ↗
$12,96
Preço · Ago 18, 2026
Fundamentais a partir de Ago 13, 2026

Sobre USANA Health Sciences, Inc. Common Stock Visão geral da empresa da Wikipedia

USANA Health Sciences, Inc., or USANA, is an American multi-level marketing company based in Salt Lake City, Utah. As of 2021, USANA was the 14th largest direct-selling company in the world by revenue. The company manufactures most of its nutritional products, dietary supplements, and skincare products at a Salt Lake City facility. Its products are sold in 25 countries via a network of independent distributors.

Ler mais

USANA Health Sciences, Inc., or USANA, is an American multi-level marketing company based in Salt Lake City, Utah. As of 2021, USANA was the 14th largest direct-selling company in the world by revenue. The company manufactures most of its nutritional products, dietary supplements, and skincare products at a Salt Lake City facility. Its products are sold in 25 countries via a network of independent distributors.

History

In 1992, immunologist and microbiologist Myron Wentz moved his diagnostic testing company, Gull Laboratories, from Salt Lake City to West Valley City, Utah, and spun it into USANA Health Services, a multilevel marketing manufacturer of supplements. Beginning in 1993, Dallin A. Larsen served as USANA's vice president of sales (and later as a consultant to USANA's president and special advisor to the board of directors) before founding the MLM beverage company Monavie in 2005. USANA's products are not available through retail channels, and can only be obtained through one of its independent distributors (referred to as "associates") or by direct order through the company.

On 20 February 2007, Barry Minkow, founder of the Fraud Discovery Institute, distributed a 500-page report to officials at the U.S. Securities and Exchange Commission (SEC), the Federal Bureau of Investigation (FBI), and the Internal Revenue Service (IRS) accusing USANA of operating an illegal pyramid scheme. The SEC conducted an investigation into USANA's business practices in March 2007 and found no evidence of wrongdoing, concluding its inquiry with no enforcement action recommended. Minkow acknowledged that he was shorting USANA's shares, hoping to profit from a drop in the stock price. In April 2007, a class action lawsuit was filed alleging that USANA's common stock had been artificially inflated. In August 2007, USANA was notified by the Securities and Exchange Commission (SEC) that its shares were subject to delisting from the NASDAQ due to its Form 10-Q, and was determined to be in compliance that October.

In January 2008, a shareholder suit was filed with allegations that USANA had misled investors about the sustainability of its growth and business model. The cases were dismissed, and the company was cleared by the U.S. Securities and Exchange Commission after an informal inquiry into the allegations, stating that it did "not intend to recommend any enforcement action by the Commission." Later that year, two Canadian USANA distributors were awarded $7 million in damages for their wrongful dismissal from the company. The firm had terminated their positions in 2003 because it believed the distributor had violated the companies' policies and procedures.

USANA filed suits against Minkow and his company claiming defamation and stock manipulation. USANA dropped the defamation suit and in March 2008 U.S. District Judge Tena Campbell threw out four of the five claims brought by USANA against Minkow ruling that USANA's claims violated California's anti-SLAPP law for suing Minkow for fair criticism and that USANA did not show a reasonable probability of winning on those claims. The remaining charge of stock manipulation was settled in July 2008, when USANA and Minkow reached an undisclosed settlement that included the removal of all USANA-related materials from the Fraud Discovery Institute website, a related Chinese website, and YouTube. Minkow also agreed to never trade in USANA's stock again.

In December 2010, USANA completed the application process to transfer its common stock listing from the NASDAQ National Market System, where it had traded since 1996, to the New York Stock Exchange. The transfer became official at the beginning of 2011. It received drug-establishment registration from the Food and Drug Administration to manufacture over-the-counter drugs later that year. In 2012, 91% of product sales were purchased by associates. The company acquired BabyCare Ltd., a China-based prenatal supplement company, in 2013 and announced plans to build a manufacturing facility in the country.

By 2018, USANA had reported record revenue due to growth in the Asia-Pacific region, though it recorded a 7% drop in net sales during its 2019 annual report. USANA has partnered with HealthCorps on health education for children and, in 2019, the USANA Foundation's Kids Eat program opened a facility to pack and distribute food for childhood hunger in the Utah area. It was also announced as the official nutritional partner of the Spartan Race endurance brand in the United States. Its sales for the first quarter of 2020 declined by 2.3 percent compared with 2019 numbers.

In February 2019, the Ministry of Commerce in China suspended operations of all multi-level marketing companies and participants to conduct a 100-day review of the country's health foods industry due to exaggerated advertising claims and questionable products in the unregulated sector. Chinese departments initiated "Hundred Days of Action" to clean up the health market, where 49 products from various companies were revoked, 54 food business licenses of various companies were revoked, 90 business licenses of various companies were revoked, and 465 counterfeit and fake dens were destroyed. 85 companies, including BabyCare Ltd., a USANA subsidiary, signed a declaration to self-discipline and regulate operations, with BabyCare speaking at an event hosted by the Chinese government.

Corporate affairs

Leadership

In 2007, USANA faced repeated controversy after members of its board of directors, medical advisory board and several of its executives made false statements regarding their qualifications, including education and licenses.

Founder Myron Wentz was the company's chief executive officer from 1992 until 2008, when his son, Dave Wentz, succeeded him after working in positions such as president, executive vice president, and senior vice president of strategic development. In 2015, USANA announced that the chief executive officer role would be divided between Wentz and Kevin Guest, with the former taking global operations and the latter, field development and sales. Guest was appointed the sole chief executive officer in November 2016.

Operations

USANA, a multilevel marketing company, sells its products primarily through non-employee distributors, known as sales "associates", as well as through the Internet. The firm's 2010 income disclosure statement defines "associates" as those who are actively building a business, acting as wholesale buyers, or are new distributors. The firm's 2009 SEC 10-K filing distinguishes between associates and preferred customers. Associates are independent distributors of USANA products and also purchase them for personal use. Preferred customers may purchase products at wholesale prices strictly for personal use and are not permitted to resell or distribute them. As of July 2011, the firm had 222,000 active Associates and 68,000 preferred customers. It manufactured 90% of its products at the Salt Lake City headquarters, which produced more than 22 million tablets each week.

Associates may be eligible to receive commissions based on their own product sales as well as through sales made by any new distributors they recruit. According to documentation from USANA corporate, 87 percent of associates fail to make enough from commissions to recover the cost of their qualifying purchases with 67 percent of all associates making no commission; the top 2.31 percent of associates earns 72.2 percent of the company's commissions. According to a 2011 article published by the Salt Lake City Tribune, the firm's FY09 income disclosure statement indicated that the average yearly income of the company's 165,710 associates, which includes those just starting, was $617, while the "top-of-the-pyramid distributors earn an average of $857,865 annually".

Sponsorships

USANA has been a paid sponsor of various athletic organizations. USANA offers an "Athlete Guarantee Program" to select sponsored athletes. The program permits selected participants to enter into an agreement with the company stipulating that, should an athlete enrolled in the program test positive for a banned substance (included in World Anti-Doping Agency regulations) as a result of taking USANA products, the company will compensate the athlete up to two times his or her current annual earnings up to $1 million USD.

In 2006, USANA signed a co-sponsorship agreement with the WTA Tour and extended it in 2011. The agreement provides athletes with nutritional supplements that are guaranteed to conform to the Tour's antidoping policy. As part of the agreement in 2011, USANA donated $1 to Children's Hunger Fund for every ace scored at a WTA tournament beginning at Wimbledon and continuing through the end of the season.

In 2003, USANA became the title sponsor of the USANA Amphitheatre, an outdoor amphitheatre based in West Valley City, Utah with a seating capacity of 20,000. In May 2012, United Concerts announced a continued naming rights partnership with USANA Health Sciences through March 2018.

In the lead-up to the 2020 Summer Olympics, USANA announced partnerships with USA Swimming and the USA Skateboarding National Team. It was the official multivitamin sponsor of USA Swimming and official nutritional supplement supplier of USA Skateboarding. The partnerships reportedly extended into multi-year agreements.

Products

USANA produces three product lines: USANA Nutritionals (Cellsentials, Optimizers, and Digestion/Detox nutritional supplements), USANA Diet & Energy (Reset meal replacement shakes, protein bars, and Rev3 energy drinks), and Sensé & Celavive personal care (skin care, skin treatment, and hair & body care products).

USANA Essentials were tested in 2011 by ConsumerLab.com in its Multivitamin and Multimineral Supplements Review of 38 leading multivitamin/multimineral products sold in the U.S. and Canada. The Essentials passed ConsumerLab's test, which included testing of selected index elements, their ability to disintegrate in solution per United States Pharmacopeia guidelines, lead contamination threshold set in California Proposition 65, and meeting U.S. Food and Drug Administration (FDA) labeling requirements.

As of 2019, its products are marketed in the United States, Canada, Australia, New Zealand, Hong Kong, Japan, Taiwan, South Korea, Singapore, Mexico, Malaysia, the Netherlands, the United Kingdom, the Caribbean, Puerto Rico, Philippines, France, China, Spain, Italy, Germany, Romania, Denmark, Colombia and Indonesia.

Reception

From 2004 to 2006, USANA was named on Forbes "200 Best Small Companies" list. In 2007, a Forbes article quoted industry experts and government officials who had raised questions about the cost of USANA's supplements and its business practices. Radio-Canada later aired an investigative report that examined the company's products, pricing and "misleading income claims" made to potential associates concerning revenue. It included hidden-camera footage of recruitment and other sessions, which found one group of associates appeared to violate the company's policies and distributor agreements. This contrasted with the Canadian legal requirements for multi-level marketing companies to provide clear, frequent and complete information about the revenue of the typical participant. In addition, the same group of associates were filmed making recommendations for using USANA products to treat illnesses including leukemia.

John Cloud, senior writer for Time Magazine, evaluated nutritional supplements in which he took a regimen of USANA pills, protein bars, powder drinks and psyllium fiber as recommended by the company's online evaluation. Cloud took a blood test before starting the products to measure levels of calcium, protein, sodium, cholesterol, glucose, and other substances, and was then tested again five months after starting the supplement regimen, which included 3,000 pills at a cost of $1,200. The follow-up test revealed a change in only two values; a 75% increase in vitamin D levels (attributed to the vitamin D3 supplement Cloud had been taking) and a 28 mg/dl increase in high-density lipoprotein, which could not be accounted for. Cloud also experienced a placebo response where that act of taking the supplements made him feel more vigorous despite no physiological reasons being present. This response also led to a 10-lb weight gain, as the belief that he was more vigorous led him to make poorer dietary decisions—a phenomenon referred to as the "licensing effect".

New Zealand government statistician for the Commerce Commission, Murray H. Smith, who served as an expert witness in every pyramid scheme case brought by the Commission preceding 10 years, opined in 2008 that very few USANA distributors are likely to become wealthy, and stated, "you can make a very strong argument that this could be a pyramid scheme." When asked by the National Business Review to review the firm's business structure and compensation plan, it was Smith's opinion, from a statistical not legal standpoint, that the firm demonstrated a number of characteristics commonly occurring in pyramid schemes including that most members recoup less than what they pay to participate; that those at the top of the structure are more likely to make more than those on the bottom of the structure; and that as the company grows it will become harder to recruit others. Smith also noted the company's significant turnover in distributors making it necessary to continually recruit.

Fonte: Wikipedia (Inglês), CC BY-SA 4.0 · Ver na Wikipedia ↗

Wikidata ↗

USNA Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas

Preço
$12.96
Capitalização de Mercado
$239M
P/E (TTM)
22.6
EPS (TTM)
$0.58
Receita (TTM)
$925M
Rendimento div.
ROE
2.0%
Dívida/Capital
Intervalo 52 Semanas
$13 – $32

USNA Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização

Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS

Receita e Lucro Líquido $925M
10-point trend, -8.0%
2016-12-31 2026-01-03
EPS $0.58
10-point trend, -85.5%
2016-12-31 2026-01-03
Fluxo de caixa livre $9M
10-point trend, -91.8%
2016-12-31 2026-01-03
Margens 1.2%
10-point trend, -4.6%
2016-12-31 2026-01-03

Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?

Métrica
Tendência de 5 anos
USNA
Mediana de Pares
P/E (TTM)
5-point trend, +89.8%
22.6
15.6
P/S (TTM)
5-point trend, -76.8%
0.3
0.6
P/B
5-point trend, -86.6%
0.4
2.6
Price / FCF (Preço / FCF)
5-point trend, +130.4%
28.1

Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC

Métrica
Tendência de 5 anos
USNA
Mediana de Pares
Gross Margin (Margem Bruta)
5-point trend, -4.1%
78.3%
69.1%
Operating Margin (Margem Operacional)
5-point trend, -71.8%
4.0%
Net Profit Margin (Margem de Lucro Líquido)
5-point trend, -88.2%
1.2%
3.9%
ROA
5-point trend, -92.5%
1.4%
5.0%
ROE
5-point trend, -93.1%
2.0%
9.6%
ROIC
5-point trend, -93.4%
1.9%

Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial

Métrica
Tendência de 5 anos
USNA
Mediana de Pares
Current Ratio (Índice de liquidez corrente)
5-point trend, -1.2%
2.2
2.5
Quick Ratio (Índice de Liquidez Seca)
5-point trend, -17.4%
1.2

Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos

Métrica
Tendência de 5 anos
USNA
Mediana de Pares
Revenue YoY (Receita Ano a Ano)
5-point trend, -22.0%
8.3%
Revenue CAGR 3Y (CAGR Receita 3A)
5-point trend, -22.0%
-2.5%
Revenue CAGR 5Y (CAGR Receita 5A)
5-point trend, -22.0%
-4.0%
EPS YoY
5-point trend, -89.9%
-73.5%
Net Income YoY (Lucro Líquido Ano a Ano)
5-point trend, -90.8%
-74.4%

Métricas por Ação EPS, valor patrimonial por ação, fluxo de caixa por ação, dividendo por ação

Métrica
Tendência de 5 anos
USNA
Mediana de Pares
EPS (Diluted) (EPS (Diluído))
5-point trend, -89.9%
$0.58

Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber

Métrica
Tendência de 5 anos
USNA
Mediana de Pares

USNA Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta

VENDA 6 analistas
  • Compra forte 0 0,0%
  • Compra 0 0,0%
  • Manter 3 50,0%
  • Venda 1 16,7%
  • Venda forte 2 33,3%

Preço-alvo de 12 meses

1 analistas · 2026-08-14
Alvo mediano $25.00 +92,8%
Alvo médio $25.00 +92,8%

Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados

Surpresa Média
-0.10%
Período EPS Actual EPS est. Surpresa
30 de Junho de 2026 $-0.07 $0.44 -0.51%
31 de Março de 2026 $0.61 $0.45 0.16%
31 de Dezembro de 2025 $0.60 $0.42 0.18%
30 de Setembro de 2025 $-0.15 $0.48 -0.63%
30 de Junho de 2025 $0.74 $0.55 0.19%
31 de Março de 2025 $0.73 $0.71 0.02%

Comparação de pares (subindústria GICS) Métricas chave vs pares do setor

Ticker Capitalização de Mercado P/E Receita YoY Margem Líquida ROE Margem Bruta
USNA $355M 33.5 8.3% 1.2% 2.0% 78.3%
BRBR $4.39B 21.6 16.1% 9.3% -72.0% 33.3%
HNST $291M -18.4 -1.9% -4.2% -8.8% 33.3%
NATR $378M 20.4 5.7% 4.1% 12.0% 72.4%
NAGE $507M 31.8 29.9% 13.4% 24.7% 64.3%
NUS 3.0 -14.3% 10.8% 22.0% 69.5%
MED $117M -6.3 -36.0% -4.8% -9.0% 71.3%

Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa

Demonstração de Resultados 18
Dados anuais de Demonstração de Resultados para USNA
Métrica Tendência 202520242023202220212020201920182017201620152014
Revenue 12-point trend, +17.1% $925M $855M $921M $999M $1.19B $1.13B $1.06B $1.19B $1.05B $1.01B $918M $790M
Cost of Revenue 12-point trend, +42.7% $201M $161M $177M $194M $218M $209M $188M $201M $179M $180M $160M $141M
Gross Profit 12-point trend, +11.5% $724M $693M $744M $805M $969M $926M $873M $989M $868M $826M $759M $650M
R&D Expense 12-point trend, +108.5% $11M $12M $11M $12M $11M $11M $10M $10M $9M $9M $6M $5M
SG&A Expense 12-point trend, +82.8% $337M $263M $257M $262M $279M $261M $268M $275M $265M $234M $209M $185M
Operating Expenses 12-point trend, +28.7% $687M $627M $651M $697M $798M $749M $727M $800M $735M $687M $617M $534M
Operating Income 12-point trend, -67.8% $37M $66M $93M $108M $170M $176M $146M $188M $133M $139M $142M $116M
Interest Expense 10-point trend, +103.1% · · $262.0K $192.0K $57.0K $507.0K $66.0K $36.0K $46.0K $444.0K $15.0K $129.0K
Interest Income 12-point trend, +383.0% $2M $11M $10M $4M $3M $3M $5M $4M $2M $1M $1M $500.0K
Other Non-op 12-point trend, +407.6% $3M $-1M $7.0K $-3M $-2M $-571.0K $-335.0K $-1M $-3.0K $-1M $-174.0K $-820.0K
Pretax Income 12-point trend, -64.1% $42M $76M $102M $109M $171M $178M $150M $192M $135M $139M $143M $116M
Income Tax 12-point trend, -23.0% $30M $34M $39M $39M $54M $53M $50M $65M $72M $39M $48M $39M
Net Income 12-point trend, -86.0% $11M $42M $64M $69M $117M $125M $101M $126M $63M $100M $95M $77M
EPS (Basic) 12-point trend, -80.0% $0.58 $2.20 $3.31 $3.60 $5.78 $5.89 $4.44 $5.24 $2.57 $4.14 $3.72 $2.90
EPS (Diluted) 12-point trend, -79.3% $0.58 $2.19 $3.30 $3.59 $5.73 $5.86 $4.41 $5.12 $2.53 $3.99 $3.59 $2.80
Shares (Basic) 12-point trend, -29.9% 18,535,000 19,103,000 19,250,000 19,254,000 20,146,000 21,156,000 22,644,000 24,105,000 24,349,000 24,185,000 25,460,000 26,443,000
Shares (Diluted) 12-point trend, -32.2% 18,574,000 19,162,000 19,345,000 19,310,000 20,343,000 21,256,000 22,818,000 24,642,000 24,708,000 25,047,000 26,355,000 27,377,000
EBITDA 12-point trend, -44.0% $70M $81M $106M $121M $183M $190M $161M $205M $149M $152M $152M $125M
Balanço Patrimonial 26
Dados anuais de Balanço Patrimonial para USNA
Métrica Tendência 202520242023202220212020201920182017201620152014
Cash & Equivalents 12-point trend, +42.5% $158M $182M $330M $288M $240M $312M $235M $214M $247M $176M $143M $111M
Receivables $4M · · · · · · · · · · ·
Inventory 12-point trend, +126.8% $103M $70M $61M $67M $98M $90M $69M $82M $63M $65M $66M $45M
Prepaid Expense 12-point trend, -33.1% $23M $28M $26M $29M $27M $23M $26M $33M $30M $37M $35M $35M
Other Current Assets 12-point trend, -13.7% $5M $5M $6M $7M $4M $5M $5M $7M $5M $6M $5M $6M
Current Assets 12-point trend, +51.1% $288M $279M $418M $384M $365M $425M $329M $392M $340M $278M $244M $191M
PP&E (Net) 12-point trend, +32.6% $94M $95M $100M $98M $102M $100M $95M $92M $103M $101M $88M $71M
PP&E (Gross) 10-point trend, +86.4% · · $212M $210M $211M $199M $181M $178M $177M $164M $120M $114M
Accum. Depreciation 12-point trend, +109.1% $135M $130M $129M $125M $122M $116M $105M $96M $86M $76M $71M $64M
Goodwill 12-point trend, +669.0% $138M $144M $17M $17M $18M $17M $17M $17M $17M $17M $17M $18M
Intangibles 12-point trend, +225.1% $133M $152M $30M $32M $30M $31M $30M $32M $35M $34M $38M $41M
Other Non-current Assets 12-point trend, +161.1% $62M $59M $55M $55M $58M $62M $43M $18M $21M $22M $25M $24M
Total Assets 12-point trend, +111.9% $743M $748M $633M $597M $578M $641M $517M $554M $519M $471M $423M $351M
Accounts Payable 12-point trend, +121.9% $17M $12M $10M $11M $14M $18M $13M $10M $12M $9M $10M $8M
Accrued Liabilities 3-point trend, -2.6% $10M $14M $10M · · · · · · · · ·
Current Liabilities 12-point trend, +18.3% $129M $140M $119M $144M $161M $168M $136M $149M $141M $138M $131M $109M
Capital Leases 6-point trend, -28.8% $12M $10M $5M $8M $10M · $17M · · · · ·
Deferred Tax 12-point trend, -53.9% $5M $4M $5M $4M $7M $12M $10M $13M $14M $5M $10M $11M
Other Non-current Liabilities 12-point trend, +1981.3% $23M $18M $12M $14M $14M $19M $19M $1M $1M $1M $1M $1M
Total Liabilities 3-point trend, +15.6% $157M $162M $136M · · · · · · · · ·
Common Stock 12-point trend, +38.5% $18.0K $19.0K $19.0K $19.0K $19.0K $21.0K $22.0K $24.0K $24.0K $24.0K $25.0K $13.0K
Retained Earnings 12-point trend, +179.9% $466M $479M $445M $392M $345M $383M $306M $330M $288M $265M $215M $166M
AOCI 12-point trend, -858.8% $-16M $-23M $-14M $-13M $458.0K $-4M $-14M $-10M $-1M $-12M $-4M $2M
Stockholders' Equity 12-point trend, +131.6% $533M $532M $497M $434M $395M $442M $352M $391M $363M $325M $281M $230M
Liabilities + Equity 12-point trend, +111.9% $743M $748M $633M $597M $578M $641M $517M $554M $519M $471M $423M $351M
Shares Outstanding 12-point trend, -27.6% 18,281,000 19,064,000 19,130,000 19,206,000 19,393,000 21,038,000 21,655,000 23,567,000 24,024,000 24,485,000 24,976,000 25,266,000
Fluxo de Caixa 16
Dados anuais de Fluxo de Caixa para USNA
Métrica Tendência 202520242023202220212020201920182017201620152014
D&A 12-point trend, +269.6% $33M $15M $13M $13M $13M $14M $15M $17M $16M $13M $10M $9M
Stock-based Comp 12-point trend, +41.0% $14M $15M $15M $13M $14M $14M $16M $15M $15M $17M $11M $10M
Deferred Tax 12-point trend, -586.8% $-7M $-7M $-3M $-7M $-3M $-2M $-4M $607.0K $19M $-4M $-3M $-1M
Amort. of Intangibles 12-point trend, +4382.1% $19M $2M $2M $2M $1M $1M $1M $2M $1M $2M $900.0K $431.0K
Restructuring 3-point trend, +6463000.00 $6M $0 $0 · · · · · · · · ·
Other Non-cash 12-point trend, -352.1% $-28M $-3M $-18M $15M $-20M $10M $-442.0K $-7M $10M $11M $-2M $11M
Operating Cash Flow 12-point trend, -78.8% $22M $61M $71M $104M $121M $160M $127M $152M $124M $137M $111M $105M
CapEx 12-point trend, -32.3% $14M $10M $14M $10M $13M $15M $17M $11M $13M $33M $24M $20M
Investing Cash Flow 12-point trend, +37.8% $-10M $-213M $-12M $-12M $-14M $-34M $47M $-69M $-13M $-32M $-25M $-16M
Stock Repurchased 12-point trend, -80.2% $28M $9M $12M $25M $178M $57M $150M $105M $50M $65M $61M $139M
Net Stock Activity 12-point trend, +80.2% $-28M $-9M $-12M $-25M $-178M $-57M $-150M $-105M $-50M $-65M $-61M $-139M
Financing Cash Flow 12-point trend, +64.1% $-41M $10M $-14M $-30M $-181M $-59M $-152M $-105M $-50M $-65M $-49M $-113M
Net Change in Cash 12-point trend, +11.2% $-23M $-149M $42M $48M $-72M $78M $20M $-33M $72M $32M $32M $-26M
Taxes Paid 3-point trend, -12.2% $37M $40M $42M · · · · · · · · ·
Free Cash Flow 12-point trend, -89.9% $9M $51M $56M $94M $108M $145M $110M $141M $111M $104M $88M $85M
Levered FCF 10-point trend, -33.9% · · $56M $93M $108M $145M $110M $141M $111M $104M $88M $85M
Lucratividade 8
Dados anuais de Lucratividade para USNA
Métrica Tendência 202520242023202220212020201920182017201620152014
Gross Margin 12-point trend, -4.7% 78.3% 81.1% 80.8% 80.6% 81.6% 81.6% 82.3% 83.1% 82.9% 82.1% 82.6% 82.2%
Operating Margin 12-point trend, -72.4% 4.0% 7.8% 10.1% 10.8% 14.3% 15.6% 13.8% 15.8% 12.7% 13.8% 15.4% 14.7%
Net Margin 12-point trend, -88.0% 1.2% 4.9% 6.9% 6.9% 9.8% 11.0% 9.5% 10.6% 6.0% 9.9% 10.3% 9.7%
Pretax Margin 12-point trend, -69.3% 4.5% 8.9% 11.1% 10.9% 14.4% 15.7% 14.2% 16.1% 12.9% 13.8% 15.5% 14.6%
EBITDA Margin 12-point trend, -52.2% 7.6% 9.5% 11.5% 12.1% 15.4% 16.8% 15.2% 17.2% 14.2% 15.1% 16.5% 15.8%
ROA 12-point trend, -93.2% 1.4% 6.1% 10.4% 11.8% 19.1% 21.5% 18.8% 23.5% 12.6% 22.4% 24.5% 21.3%
ROE 12-point trend, -93.5% 2.0% 7.9% 13.2% 16.4% 29.3% 30.0% 30.2% 30.5% 17.2% 33.0% 37.0% 31.2%
ROIC 12-point trend, -94.2% 1.9% 6.9% 11.7% 15.8% 29.4% 28.0% 27.8% 31.7% 16.9% 30.8% 33.5% 33.4%
Liquidez e Solvência 3
Dados anuais de Liquidez e Solvência para USNA
Métrica Tendência 202520242023202220212020201920182017201620152014
Current Ratio 12-point trend, +27.7% 2.2 2.0 3.5 2.7 2.3 2.5 2.4 2.6 2.4 2.0 1.9 1.8
Quick Ratio 12-point trend, +20.5% 1.2 1.3 2.8 2.0 1.5 1.9 1.7 1.4 1.8 1.3 1.1 1.0
Interest Coverage 10-point trend, -60.5% · · 355.2 560.5 2985.8 348.1 2215.0 5232.0 2880.5 312.2 9444.1 900.0
Eficiência 2
Dados anuais de Eficiência para USNA
Métrica Tendência 202520242023202220212020201920182017201620152014
Asset Turnover 12-point trend, -43.6% 1.2 1.2 1.5 1.7 1.9 2.0 2.0 2.2 2.1 2.3 2.4 2.2
Inventory Turnover 12-point trend, -23.4% 2.3 2.5 2.7 2.3 2.3 2.2 2.5 2.8 2.8 2.8 2.9 3.0
Por Ação 5
Dados anuais de Por Ação para USNA
Métrica Tendência 202520242023202220212020201920182017201620152014
Book Value / Share 12-point trend, +60.1% $29.16 $27.91 $25.99 $22.62 $20.37 $20.99 $16.24 $16.60 $15.12 $13.29 $22.49 $18.22
Revenue / Share 12-point trend, -13.7% $49.81 $44.59 $47.61 $51.71 $58.32 $53.38 $46.49 $48.26 $42.39 $40.17 $69.70 $57.74
Cash Flow / Share 12-point trend, -84.3% $1.20 $3.18 $3.65 $5.38 $5.96 $7.55 $5.55 $6.17 $5.01 $5.47 $8.46 $7.68
Cash / Share 12-point trend, -1.5% $8.66 $9.53 $17.27 $15.02 $12.37 $14.83 $10.84 $9.09 $10.29 $7.18 $11.47 $8.80
EPS (TTM) 12-point trend, -79.3% $0.58 $2.19 $3.30 $3.59 $5.73 $5.86 $4.41 $5.12 $2.53 $3.99 $3.59 $2.80
Taxas de Crescimento 9
Dados anuais de Taxas de Crescimento para USNA
Métrica Tendência 202520242023202220212020201920182017201620152014
Revenue YoY 5-point trend, +81.2% 8.3% -7.2% -7.8% -15.8% 4.6% · · · · · · ·
Revenue CAGR 3Y 3-point trend, +62.6% -2.5% -10.4% -6.7% · · · · · · · · ·
Revenue CAGR 5Y -4.0% · · · · · · · · · · ·
EPS YoY 5-point trend, -3211.7% -73.5% -33.6% -8.1% -37.4% -2.2% · · · · · · ·
EPS CAGR 3Y 3-point trend, -161.4% -45.5% -27.4% -17.4% · · · · · · · · ·
EPS CAGR 5Y -37.0% · · · · · · · · · · ·
Net Income YoY 5-point trend, -1037.6% -74.4% -34.1% -8.0% -40.5% -6.5% · · · · · · ·
Net Income CAGR 3Y 3-point trend, -131.1% -46.3% -28.8% -20.0% · · · · · · · · ·
Net Income CAGR 5Y -38.7% · · · · · · · · · · ·
Avaliação (TTM) 10
Dados anuais de Avaliação (TTM) para USNA
Métrica Tendência 202520242023202220212020201920182017201620152014
Revenue TTM 12-point trend, +17.1% $925M $855M $921M $999M $1.19B $1.13B $1.06B $1.19B $1.05B $1.01B $918M $790M
Net Income TTM 12-point trend, -86.0% $11M $42M $64M $69M $117M $125M $101M $126M $63M $100M $95M $77M
Market Cap 12-point trend, -45.0% $355M $680M $1.03B $1.02B $1.96B $1.62B $1.73B $2.71B $1.78B $1.50B $798M $646M
P/E 12-point trend, +83.5% 33.5 16.3 16.2 14.8 17.7 13.2 18.1 22.5 29.3 15.3 17.8 18.3
P/S 12-point trend, -53.0% 0.4 0.8 1.1 1.0 1.7 1.4 1.6 2.3 1.7 1.5 0.9 0.8
P/B 12-point trend, -76.3% 0.7 1.3 2.1 2.4 5.0 3.7 4.9 6.9 4.9 4.6 2.8 2.8
P / Tangible Book 6-point trend, -67.1% 1.4 2.9 2.3 2.7 5.7 4.1 · · · · · ·
P / Cash Flow 12-point trend, +158.9% 15.9 11.2 14.5 9.8 16.2 10.1 13.7 17.8 14.4 10.9 7.2 6.1
P / FCF 12-point trend, +446.9% 41.7 13.4 18.3 10.9 18.1 11.2 15.7 19.3 16.1 14.4 9.1 7.6
Earnings Yield 12-point trend, -45.6% 3.0% 6.1% 6.2% 6.8% 5.7% 7.6% 5.5% 4.5% 3.4% 6.5% 5.6% 5.5%

Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos

Demonstração de Resultados
2026-01-032024-12-282023-12-302022-12-312022-01-01
Receita $925M$855M$921M$999M$1.19B
Margem Bruta % 78.3%81.1%80.8%80.6%81.6%
Margem Operacional % 4.0%7.8%10.1%10.8%14.3%
Lucro líquido $11M$42M$64M$69M$117M
EPS Diluído $0.58$2.19$3.30$3.59$5.73
Balanço Patrimonial
2026-01-032024-12-282023-12-302022-12-312022-01-01
Índice de liquidez corrente 2.22.03.52.72.3
Índice de Liquidez Seca 1.21.32.82.01.5
Fluxo de Caixa
2026-01-032024-12-282023-12-302022-12-312022-01-01
Fluxo de caixa livre $9M$51M$56M$94M$108M

Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos

📊

Escolha as métricas que importam para você — clique no ➕ ao lado de qualquer linha em Fundamentos Completos acima.

Sua seleção é salva e acompanha você em todos os tickers.

Investidores institucionais (13F) 152 declarantes · $176.6M total · Em 30 de Junho de 2026

Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.

Atividade institucional — Q2 2026 vs trimestre anterior
Novas posições Posições encerradas Aumentou Diminuído Variação líquida de ações
30 (+4 vs trimestre anterior) 16 (+6 vs trimestre anterior) 48 (+5 vs trimestre anterior) 34 (-7 vs trimestre anterior) +1.1M

Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.

Instituição Valor Ações % de 13F rastreado Tipo
PZENA INVESTMENT MANAGEMENT LLC $25.739.282 1.205.587 14,58% Ações
RENAISSANCE TECHNOLOGIES LLC $20.464.402 958.520 11,59% Ações
Nantahala Capital Management, LLC $17.295.080 810.074 9,80% Ações
DIMENSIONAL FUND ADVISORS LP $16.958.134 794.292 9,61% Ações
VANGUARD CAPITAL MANAGEMENT LLC $10.405.350 487.370 5,89% Ações
VANGUARD PORTFOLIO MANAGEMENT LLC $7.758.099 363.377 4,39% Ações
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $5.811.641 272.208 3,29% Ações
STATE STREET CORP $5.577.474 261.240 3,16% Ações
GEODE CAPITAL MANAGEMENT, LLC $5.175.448 242.342 2,93% Ações
AMERICAN CENTURY COMPANIES INC $3.999.880 187.348 2,27% Ações
JACOBS LEVY EQUITY MANAGEMENT, INC $3.855.105 180.567 2,18% Ações
TWO SIGMA INVESTMENTS, LP $3.533.724 165.514 2,00% Ações
D. E. Shaw & Co., Inc. $3.348.427 156.835 1,90% Ações
Allianz Asset Management GmbH $3.040.219 142.399 1,72% Ações
BRIDGEWAY CAPITAL MANAGEMENT, LLC $2.949.567 138.153 1,67% Ações
ALGERT GLOBAL LLC $2.813.033 131.758 1,59% Ações
UBS Group AG $2.474.166 115.886 1,40% Ações
BlackRock, Inc. $2.353.005 110.211 1,33% Ações
LAZARD ASSET MANAGEMENT LLC $2.077.590 97.311 1,18% Ações
VANGUARD FIDUCIARY TRUST CO $1.549.540 72.578 0,88% Ações
Vanguard Global Advisers, LLC $1.514.569 70.940 0,86% Ações
Empowered Funds, LLC $1.499.902 70.253 0,85% Ações
AMERIPRISE FINANCIAL INC $1.443.624 67.617 0,82% Ações
TWO SIGMA ADVISERS, LP $1.289.691 65.700 0,73% Ações
GOLDMAN SACHS GROUP INC $1.121.921 52.549 0,64% Ações
Quantinno Capital Management LP $1.072.261 50.223 0,61% Ações
BANK OF AMERICA CORP /DE/ $967.539 45.318 0,55% Ações
ROYCE & ASSOCIATES LP $884.039 41.407 0,50% Ações
DEUTSCHE BANK AG\ $821.975 38.500 0,47% Ações
Assenagon Asset Management S.A. $815.848 38.213 0,46% Ações
BARCLAYS PLC $769.220 36.029 0,44% Ações
STRS OHIO $723.765 33.900 0,41% Ações
Skopos Labs, Inc. $673.696 38.563 0,38% Ações
HSBC HOLDINGS PLC $672.758 31.960 0,38% Ações
Bank of New York Mellon Corp $668.447 31.309 0,38% Ações
XTX Topco Ltd $625.320 29.289 0,35% Ações
MILLENNIUM MANAGEMENT LLC $570.728 26.732 0,32% Ações
CITADEL ADVISORS LLC $569.639 26.681 0,32% Ações
Verdad Advisers, LP $556.552 26.068 0,32% Ações
Sanctuary Advisors, LLC $497.113 23.284 0,28% Ações
Man Group plc $489.854 22.944 0,28% Ações
State of Tennessee, Department of Treasury $461.160 21.600 0,26% Ações
Point72 Asset Management, L.P. $397.238 18.606 0,22% Ações
Unison Advisors LLC $384.300 18.000 0,22% Ações
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO $384.215 17.996 0,22% Ações
Numerai GP LLC $382.080 17.896 0,22% Ações
KLP KAPITALFORVALTNING AS $375.760 17.600 0,21% Ações
Connor, Clark & Lunn Investment Management Ltd. $366.836 17.182 0,21% Ações
ALLIANCEBERNSTEIN L.P. $357.611 20.470 0,20% Ações
CITADEL ADVISORS LLC $356.545 16.700 0,20% Opção de venda
Park Capital Management, LLC / WI $345.144 16.166 0,20% Ações
Engineers Gate Manager LP $337.672 15.816 0,19% Ações
SEGALL BRYANT & HAMILL, LLC $318.414 14.914 0,18% Ações
RHUMBLINE ADVISERS $309.778 14.510 0,18% Ações
Vanguard Personalized Indexing Management, LLC $309.724 14.507 0,18% Ações
FIRST TRUST ADVISORS LP $308.998 14.473 0,18% Ações
Toroso Investments, LLC $304.756 15.525 0,17% Ações
EXCHANGE TRADED CONCEPTS, LLC $300.992 14.098 0,17% Ações
IEQ CAPITAL, LLC $300.245 14.063 0,17% Ações
Y-Intercept (Hong Kong) Ltd $298.366 13.975 0,17% Ações
Focus Partners Wealth $292.794 13.714 0,17% Ações
CITADEL ADVISORS LLC $273.280 12.800 0,15% Opção de compra
BNP PARIBAS FINANCIAL MARKETS $263.160 12.326 0,15% Ações
MERCER GLOBAL ADVISORS INC /ADV $243.881 11.423 0,14% Ações
State of Wyoming $242.237 11.346 0,14% Ações
ANCHYRA PARTNERS LLC $230.238 10.784 0,13% Ações
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP $229.982 10.772 0,13% Ações
OCCUDO QUANTITATIVE STRATEGIES LP $226.652 10.616 0,13% Ações
Mariner, LLC $219.915 10.302 0,12% Ações
DGS Capital Management, LLC $207.876 11.899 0,12% Ações
Cerity Partners LLC $141.913 6.647 0,08% Ações
Magnetar Financial LLC $138.540 6.489 0,08% Ações
MetLife Investment Management, LLC $124.236 5.819 0,07% Ações
Russell Investments Group, Ltd. $123.637 5.791 0,07% Ações
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. $109.931 5.149 0,06% Ações
Creative Planning $107.156 5.019 0,06% Ações
FMR LLC $105.661 4.949 0,06% Ações
SIGNATUREFD, LLC $101.391 4.749 0,06% Ações
CWM, LLC $97.413 5.576 0,06% Ações
VANGUARD GROUP INC $96.226 4.902 0,05% Ações
Invesco Ltd. $95.072 4.453 0,05% Ações
NEW YORK STATE COMMON RETIREMENT FUND $81.045 3.796 0,05% Ações
Police & Firemen's Retirement System of New Jersey $73.935 3.463 0,04% Ações
Parallel Advisors, LLC $70.818 3.317 0,04% Ações
Farther Finance Advisors, LLC $41.873 1.964 0,02% Ações
Arax Advisory Partners $40.588 1.901 0,02% Ações
NATIONAL BANK OF CANADA /FI/ $40.499 1.896 0,02% Ações
AlphaQuest LLC $38.259 1.949 0,02% Ações
NORTHERN TRUST CORP $37.533 1.758 0,02% Ações
OSAIC HOLDINGS, INC. $34.383 1.611 0,02% Ações
LOM Asset Management Ltd $34.160 1.600 0,02% Ações
Versant Capital Management, Inc $33.904 1.588 0,02% Ações
MORGAN STANLEY $31.363 1.469 0,02% Ações
Ameritas Investment Partners, Inc. $23.933 1.121 0,01% Ações
Tower Research Capital LLC (TRC) $22.909 1.073 0,01% Ações
Legal & General Group Plc $20.966 982 0,01% Ações
Integrated Wealth Concepts LLC $18.833 882 0,01% Ações
CITIGROUP INC $17.635 826 0,01% Ações
Global Retirement Partners, LLC $14.433 676 0,01% Ações
Allworth Financial LP $14.027 657 0,01% Ações

Executivos da empresa 38 insiders · 20 diretores · 13 conselheiros

Investidor com informação privilegiada Função Última atividade Ações detidas Compras 12m Vendas 12m Líquido 12m
Jim Brown CEO & PRESIDENT 24 de Julho de 2025 M 16.934 0 0 $0
Doug G Iiekking CHIEF FINANCIAL OFFICER 27 de Maio de 2026 S 0 0 1 $-100.500
Jeffrey Yates Chief Financial Officer 28 de Outubro de 2010 M 0 0 0 $0
Deborah Woo President of Asia 8 de Setembro de 2016 M 1.479 0 0 $0
Fred W Cooper President and COO 28 de Outubro de 2010 M 0 0 0 $0
Walter Noot CHIEF OPERATING OFFICER 19 de Fevereiro de 2026 A 0 0 0 $0
Roy Truett Chief Operating Officer 27 de Julho de 2012 M 0 0 0 $0
Kathryn Michelle Armstrong CHIEF SCIENTIFIC OFFICER 25 de Julho de 2026 M 3.471 0 0 $0
Peter Benedict CHIEF INFORMATION OFFICER 25 de Julho de 2026 M 422 0 0 $0
Brent Neidig CHIEF COMMERCIAL OFFICER 16 de Junho de 2026 S 0 0 3 $-147.749
Paul A. Jones CHIEF PEOPLE OFFICER 8 de Junho de 2026 S 0 0 1 $-102.878
David Mulham Mulham CHIEF SALES OFFICER 30 de Julho de 2025 S 9.260 0 0 $0
Joshua Foukas CHIEF LEGAL OFFICER 12 de Março de 2025 S 0 0 0 $0
Daniel A. Macuga CHIEF COMMUNICATIONS OFFICER 2 de Maio de 2024 S 0 0 0 $0
Robert A Sinnott CHIEF SCIENTIFIC OFFICER 5 de Março de 2024 S 0 0 0 $0
James Bramble Chief Legal Officer and Sec 5 de Fevereiro de 2018 A 2.076 0 0 $0
Dave Wentz Co-C.E.O. 16 de Agosto de 2016 M 384.883 0 0 $0
Rick Stambaugh Chief Information Officer 17 de Dezembro de 2015 M 0 0 0 $0
Mark H Wilson E.V.P. of Sales 28 de Outubro de 2010 M 5.000 0 0 $0
Bradford Richardson E.V.P. of Asia Pacific 25 de Fevereiro de 2008 S 0 0 0 $0
Xia Ding Conselheiro 23 de Julho de 2026 M 8.278 0 0 $0
John Turman Fleming Conselheiro 23 de Julho de 2026 M 5.862 0 1 $-43.928
Peggie Pelosi Conselheiro 23 de Julho de 2026 M 6.061 0 0 $0
Scott J Nixon Conselheiro 23 de Julho de 2026 M 11.445 0 0 $0
Frederic J Winssinger Conselheiro 23 de Julho de 2026 M 9.733 0 0 $0
Timothy E Wood Conselheiro 23 de Julho de 2026 M 11.837 0 0 $0
Gilbert A Fuller Conselheiro 23 de Julho de 2026 M 1.632 0 3 $-60.414
Robert Auciaux Conselheiro 9 de Fevereiro de 2022 M 436 0 0 $0
Feng Peng Conselheiro 28 de Abril de 2021 M 755 0 0 $0
Myron W. Wentz Conselheiro 4 de Fevereiro de 2019 S 9.865.614 0 0 $0
Jerry G Mcclain Conselheiro 4 de Março de 2016 M 0 0 0 $0
Ronald S Poelman Conselheiro 8 de Fevereiro de 2016 A 0 0 0 $0
Denis E Waitley Conselheiro 3 de Novembro de 2006 M 0 0 0 $0
Gull Global Limited Detentor de 10% 4 de Fevereiro de 2019 S 9.865.614 0 0 $0
GULL HOLDINGS LTD Detentor de 10% 1 de Abril de 2015 J 6.491.110 0 0 $0
Kevin Guest 27 de Fevereiro de 2026 M 45.381 0 0 $0
Donald R. Williams 1 de Maio de 2017 A 0 0 $0
Doug Braun 16 de Dezembro de 2015 M 0 0 0 $0

Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto

Ativistas e proprietários de 5%+ 3 participações

Investidores que apresentaram o Schedule 13D da SEC — propriedade benéfica acima de 5% com a intenção de influenciar o emissor (participações ativistas, campanhas no conselho, M&A). Cada linha mostra o estado mais recente conhecido da posição desse declarante.

Declarante Declarado Participação Status Propósito Declaração
Gull Global Limited, Myron W. Wentz ×11 declarações 30 de Março de 2026 40,10% Emenda M&A / venda SEC
Gull Holdings, Ltd., Myron W. Wentz, David A. Wentz, Jacquelyn R. Wentz, Bryan Wentz, Annette Wentz, Paul & Jane Meyer Family Foundation, Paul James Meyer, Alice Jane Meyer, Centre Island Properties, Ltd., Waco Boys Club Foundation, Inc., L-K Marketing Group, LLC, Beagle Irrevocable Asset Trust 23 de Maio de 2008 Declaração inicial SEC
Paul & Jane Meyer Family Foundation 20 de Maio de 2008 Declaração inicial Investimento passivo SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Participação em ETFs Detido por 38 ETFs

O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.

Fundo Peso Unidades Em Fonte
DEEP · ETF Series Solutions 0,95% 13.646 NS 31 de Maio de 2026 N-PORT
AFSM · First Trust Exchange-Traded Fund VI… 0,25% 13.206 NS 31 de Maio de 2026 N-PORT
VFVA · VANGUARD WELLINGTON FUND 0,11% 45.046 SH 8 de Agosto de 2026 Diário
EBIT · Harbor ETF Trust 0,06% 387 NS 30 de Abril de 2026 N-PORT
IWC · iShares Trust 0,04% 38.121 SH 8 de Agosto de 2026 Diário
FNDA · SCHWAB STRATEGIC TRUST 0,03% 169.505 NS 31 de Maio de 2026 N-PORT
VDC · VANGUARD WORLD FUND 0,03% 128.565 SH 8 de Agosto de 2026 Diário
GSSC · Goldman Sachs ETF Trust 0,03% 15.259 NS 31 de Maio de 2026 N-PORT
DFSV · Dimensional ETF Trust 0,02% 87.994 NS 30 de Abril de 2026 N-PORT
VTWV · VANGUARD SCOTTSDALE FUNDS 0,02% 9.639 SH 8 de Agosto de 2026 Diário
DFAT · Dimensional ETF Trust 0,01% 97.080 NS 30 de Abril de 2026 N-PORT
PRFZ · Invesco Exchange-Traded Fund Trust 0,01% 24.189 SH 8 de Agosto de 2026 Diário
AVSC · AMERICAN CENTURY ETF TRUST 0,01% 18.642 NS 31 de Maio de 2026 N-PORT
AVUV · AMERICAN CENTURY ETF TRUST 0,01% 159.569 NS 31 de Maio de 2026 N-PORT
IWN · iShares Trust 0,01% 101.080 SH 8 de Agosto de 2026 Diário
VTWO · VANGUARD SCOTTSDALE FUNDS 0,01% 64.278 SH 8 de Agosto de 2026 Diário
DFAS · Dimensional ETF Trust 0,01% 60.807 NS 30 de Abril de 2026 N-PORT
SMLF · iShares Trust 0,01% 22.748 SH 8 de Agosto de 2026 Diário
OMFS · Invesco Exchange-Traded Self-Indexe… 0,01% 1.195 SH 8 de Agosto de 2026 Diário
RSSL · Global X Funds 0,01% 4.685 NS 30 de Abril de 2026 N-PORT
IWM · iShares Trust 0,01% 283.211 SH 8 de Agosto de 2026 Diário
ITWO · ProShares Trust 0,01% 508 NS 31 de Maio de 2026 N-PORT
SCHA · SCHWAB STRATEGIC TRUST 0,00% 51.773 NS 31 de Maio de 2026 N-PORT
FNDB · SCHWAB STRATEGIC TRUST 0,00% 2.158 NS 31 de Maio de 2026 N-PORT
UWM · ProShares Trust 0,00% 397 NS 31 de Maio de 2026 N-PORT
URTY · ProShares Trust 0,00% 406 NS 31 de Maio de 2026 N-PORT
AVSU · AMERICAN CENTURY ETF TRUST 0,00% 247 NS 31 de Maio de 2026 N-PORT
MSSM · MORGAN STANLEY PATHWAY FUNDS 0,00% 388 NS 31 de Maio de 2026 N-PORT
HDG · ProShares Trust 0,00% 10 NS 31 de Maio de 2026 N-PORT
AVUS · AMERICAN CENTURY ETF TRUST 0,00% 5.468 NS 31 de Maio de 2026 N-PORT
DFAC · Dimensional ETF Trust 0,00% 19.278 NS 30 de Abril de 2026 N-PORT
ITOT · iShares Trust 0,00% 22.758 SH 8 de Agosto de 2026 Diário
IWV · iShares Trust 0,00% 3.680 SH 8 de Agosto de 2026 Diário
SCHB · SCHWAB STRATEGIC TRUST 0,00% 6.500 NS 31 de Maio de 2026 N-PORT
DFUS · Dimensional ETF Trust 0,00% 1.784 NS 30 de Abril de 2026 N-PORT
VXF · VANGUARD INDEX FUNDS 0,00% 124.681 SH 8 de Agosto de 2026 Diário
VTI · VANGUARD INDEX FUNDS 0,00% 350.035 SH 8 de Agosto de 2026 Diário
VTHR · VANGUARD SCOTTSDALE FUNDS 0,00% 790 SH 8 de Agosto de 2026 Diário